Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

Saved in:

Bibliographic Details
Published in:	Blood Vol. 129; no. 16; pp. 2328 - 2330
Main Authors:	Zinzani, Pier Luigi, Pellegrini, Cinzia, Chiappella, Annalisa, Di Rocco, Alice, Salvi, Flavia, Cabras, Maria Giuseppina, Argnani, Lisa, Stefoni, Vittorio
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 20-04-2017
Subjects:	Adult Aged Brentuximab Vedotin Disease-Free Survival Female Humans Immunoconjugates - administration & dosage Immunoconjugates - adverse effects Lymphoma, Large B-Cell, Diffuse - drug therapy Lymphoma, Large B-Cell, Diffuse - mortality Male Mediastinal Neoplasms - drug therapy Mediastinal Neoplasms - mortality Middle Aged Recurrence Survival Rate
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0006-4971 1528-0020
DOI:	10.1182/blood-2017-01-764258